List view / Grid view

News

 

9 September 2011 GlaxoSmithKline logo

Lapatinib clinical trial update

9 September 2011 | By GSK

A planned interim review of early data from ALTTO a Phase III, four arm study of adjuvant lapatinib (Tykerb/Tyverb®), trastuzumab, has resulted in a change to the ongoing study...